
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Peptide-based synthetic vaccines
Mariusz Skwarczyński, István Tóth
Chemical Science (2015) Vol. 7, Iss. 2, pp. 842-854
Open Access | Times Cited: 526
Mariusz Skwarczyński, István Tóth
Chemical Science (2015) Vol. 7, Iss. 2, pp. 842-854
Open Access | Times Cited: 526
Showing 1-25 of 526 citing articles:
Trends in peptide drug discovery
Markus Muttenthaler, Glenn F. King, David J. Adams, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 309-325
Closed Access | Times Cited: 1319
Markus Muttenthaler, Glenn F. King, David J. Adams, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 309-325
Closed Access | Times Cited: 1319
A Global Review on Short Peptides: Frontiers and Perspectives
Vasso Apostolopoulos, Joanna Bojarska, Tsun‐Thai Chai, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 430-430
Open Access | Times Cited: 294
Vasso Apostolopoulos, Joanna Bojarska, Tsun‐Thai Chai, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 430-430
Open Access | Times Cited: 294
Current approaches of nanomedicines in the market and various stage of clinical translation
Xiaoting Shan, Xiang Gong, Jie Li, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3028-3048
Open Access | Times Cited: 208
Xiaoting Shan, Xiang Gong, Jie Li, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3028-3048
Open Access | Times Cited: 208
Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli
Mohammad Reza Asadi Karam, Mehri Habibi, Saeid Bouzari
Molecular Immunology (2019) Vol. 108, pp. 56-67
Closed Access | Times Cited: 189
Mohammad Reza Asadi Karam, Mehri Habibi, Saeid Bouzari
Molecular Immunology (2019) Vol. 108, pp. 56-67
Closed Access | Times Cited: 189
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 169
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 169
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 160
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 160
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 92
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 92
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 16
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 16
Vaccine adjuvants: smart components to boost the immune system
Rakesh Bastola, Gyubin Noh, Taekwang Keum, et al.
Archives of Pharmacal Research (2017) Vol. 40, Iss. 11, pp. 1238-1248
Closed Access | Times Cited: 137
Rakesh Bastola, Gyubin Noh, Taekwang Keum, et al.
Archives of Pharmacal Research (2017) Vol. 40, Iss. 11, pp. 1238-1248
Closed Access | Times Cited: 137
Chemical Strategies to Boost Cancer Vaccines
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Designable Immune Therapeutical Vaccine System Based on DNA Supramolecular Hydrogels
Yu Shao, Zhanyi Sun, Yijie Wang, et al.
ACS Applied Materials & Interfaces (2018) Vol. 10, Iss. 11, pp. 9310-9314
Closed Access | Times Cited: 105
Yu Shao, Zhanyi Sun, Yijie Wang, et al.
ACS Applied Materials & Interfaces (2018) Vol. 10, Iss. 11, pp. 9310-9314
Closed Access | Times Cited: 105
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
Mariusz Skwarczyński, Guangzu Zhao, Jennifer C. Boer, et al.
Science Advances (2020) Vol. 6, Iss. 5
Open Access | Times Cited: 104
Mariusz Skwarczyński, Guangzu Zhao, Jennifer C. Boer, et al.
Science Advances (2020) Vol. 6, Iss. 5
Open Access | Times Cited: 104
Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus
Reshma J. Nevagi, Zeinab G. Khalil, Waleed M. Hussein, et al.
Acta Biomaterialia (2018) Vol. 80, pp. 278-287
Open Access | Times Cited: 89
Reshma J. Nevagi, Zeinab G. Khalil, Waleed M. Hussein, et al.
Acta Biomaterialia (2018) Vol. 80, pp. 278-287
Open Access | Times Cited: 89
Antimicrobial Peptides: Potential Application in Liver Cancer
Chunye Zhang, Ming Yang, Aaron C. Ericsson
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 88
Chunye Zhang, Ming Yang, Aaron C. Ericsson
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 88
Polymers for subunit vaccine delivery
Reshma J. Nevagi, Mariusz Skwarczyński, István Tóth
European Polymer Journal (2019) Vol. 114, pp. 397-410
Closed Access | Times Cited: 86
Reshma J. Nevagi, Mariusz Skwarczyński, István Tóth
European Polymer Journal (2019) Vol. 114, pp. 397-410
Closed Access | Times Cited: 86
Peptide Vaccines for Leishmaniasis
Rory Cristiane Fortes de Brito, Jamille Mirelle de Oliveira Cardoso, Levi Eduardo Soares Reis, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 85
Rory Cristiane Fortes de Brito, Jamille Mirelle de Oliveira Cardoso, Levi Eduardo Soares Reis, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 85
Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery
Jieru Yang, Yacheng Luo, Mohini A. Shibu, et al.
Current Drug Delivery (2019) Vol. 16, Iss. 5, pp. 430-443
Open Access | Times Cited: 84
Jieru Yang, Yacheng Luo, Mohini A. Shibu, et al.
Current Drug Delivery (2019) Vol. 16, Iss. 5, pp. 430-443
Open Access | Times Cited: 84
Tumor microenvironment-oriented adaptive nanodrugs based on peptide self-assembly
Shukun Li, Wenjia Zhang, Huadan Xue, et al.
Chemical Science (2020) Vol. 11, Iss. 33, pp. 8644-8656
Open Access | Times Cited: 79
Shukun Li, Wenjia Zhang, Huadan Xue, et al.
Chemical Science (2020) Vol. 11, Iss. 33, pp. 8644-8656
Open Access | Times Cited: 79
Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
Xiaotong Chen, Ju Yang, Lifeng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 6011-6023
Open Access | Times Cited: 76
Xiaotong Chen, Ju Yang, Lifeng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 6011-6023
Open Access | Times Cited: 76
Developments in Vaccine Adjuvants
Farrhana Ziana Firdaus, Mariusz Skwarczyński, István Tóth
Methods in molecular biology (2021), pp. 145-178
Closed Access | Times Cited: 74
Farrhana Ziana Firdaus, Mariusz Skwarczyński, István Tóth
Methods in molecular biology (2021), pp. 145-178
Closed Access | Times Cited: 74
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
Xiaoling Xie, Yuxing Hu, Tong Ye, et al.
Nature Biomedical Engineering (2020) Vol. 5, Iss. 5, pp. 414-428
Closed Access | Times Cited: 73
Xiaoling Xie, Yuxing Hu, Tong Ye, et al.
Nature Biomedical Engineering (2020) Vol. 5, Iss. 5, pp. 414-428
Closed Access | Times Cited: 73
Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 563-563
Open Access | Times Cited: 73
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 563-563
Open Access | Times Cited: 73
Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold
Joanna Bojarska, Adam Mieczkowski, Zyta M. Ziora, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1515-1515
Open Access | Times Cited: 73
Joanna Bojarska, Adam Mieczkowski, Zyta M. Ziora, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1515-1515
Open Access | Times Cited: 73
Peptides for Vaccine Development
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 65
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 65